Candida auris candidaemia in Indian ICUs: Analysis of risk factors

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 6, 2017, Pages 1794-1801

  Rudramurthy, Shivaprakash M ^a   Chakrabarti, Arunaloke ^a   Paul, Raees A ^a   Sood, Prashant ^a,l   Kaur, Harsimran ^a   Capoor, Malini R ^b   Kindo, Anupma J ^c   Marak, Rungmei S K ^d   Arora, Anita ^e   Sardana, Raman ^f   Das, Shukla ^g   Chhina, Deepinder ^h   Patel, Atul ⁱ   Xess, Immaculata ^j   Tarai, Bansidhar ^k   Singh, Pankaj ^a   Ghosh, Anup ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c SRI RAMACHANDRA UNIVERSITY   (India)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^e ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^f INDRAPRASTHA APOLLO HOSPITAL   (India)

^g UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^h DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

ⁱ ID Clinic and Sterling Hospital   (India)

^j ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^k Max Hospital   (India)

^l UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; POLYENE; PYRROLE DERIVATIVE; VORICONAZOLE; ANTIFUNGAL AGENT; LIPOPEPTIDE;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIFUNGAL THERAPY; APACHE; ARTICLE; BLADDER CATHETERIZATION; CANDIDA; CANDIDA ALBICANS; CANDIDA AURIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETERIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRAINAGE CATHETER; DRUG EXPOSURE; FEMALE; HUMAN; IN VITRO STUDY; INDIA; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NEUTROPENIA; NEWBORN; NONHUMAN; PICHIA KUDRIAVZEVII; PNEUMONIA; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; VASCULAR SURGERY; AGED; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; ECHINOCANDINS; FEMALE; FLUCONAZOLE; HUMANS; INDIA; INTENSIVE CARE UNITS; LIPOPEPTIDES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; RISK FACTORS; YOUNG ADULT;

EID: 85019701846     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx034     Document Type: Article

References (28)

1. Satoh K, Makimura K, Hasumi Y et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009; 53: 41-4
2. Chowdhary A, Anil Kumar V, Sharma C et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 2014; 33: 919-26
3. Chowdhary A, Sharma C, Duggal S et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 2013; 19: 1670-3
4. Emara M, Ahmad S, Khan Z et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis 2015; 21: 1091-2
5. Magobo RE, Corcoran C, Seetharam S et al. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 2014; 20: 1250-1
6. KimMN, Shin JH, Sung H et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009; 48: e57-61
7. LeeWG, Shin JH, Uh Y et al. First three reported cases of nosocomial fungemia caused by Candida auris. J ClinMicrobiol 2011; 49: 3139-42
8. Sarma S, Kumar N, Sharma S et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol 2013; 31: 90-1
9. Schelenz S, Hagen F, Rhodes JL et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 2016; 5: 35
10. Chakrabarti A, Sood P, Rudramurthy SM et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 2015; 41: 285-95
11. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis 2017; 23: 162-4
12. Vallabhaneni S, Kallen A, Tsay S et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus-United States, May 2013-August 2016. Am J Transplant 2017; 17: 296-9
13. Lockhart SR, Etienne KA, Vallabhaneni S et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by wholegenome sequencing and epidemiological analyses. Clin Infect Dis 2017; 64: 134-40
14. Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeastsbasedonnucleotidedivergence in the50 end of the large-subunit (26S) ribosomal DNA gene. J ClinMicrobiol 1997; 35: 1216-23
15. Chakrabarti A, Rudramurthy SM, Kale P et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect 2014; 20: 83-9
16. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Third Edition: Approved Standard M27-A3. CLSI, Wayne, PA, USA, 2008
17. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational SupplementM27-S4. CLSI, Wayne, PA, USA, 2012
18. Oberoi JK, Wattal C, Goel N et al. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res 2012; 136: 997-1003
19. Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of emerging pathogen Candida auris and other key pathogenic species. mSphere 2016; 1: e00189-16
20. Calvo B, Melo ASA, Perozo-Mena A et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 2016; 73: 369-74
21. Kathuria S, Singh PK, Sharma C et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI brothmicrodilution, and Etestmethod. J ClinMicrobiol 2015; 53: 1823-30
22. Ghosh AK, Paul S, Sood P et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect 2015; 21: 372-8
23. PrakashA, SharmaC, SinghAet al. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect 2016; 22: 277
24. Girard V, Mailler S, Chetry M et al. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flightmass spectrometry. Mycoses 2016; 59: 535-8
25. Khillan V, Rathore N, Kathuria S et al. A rare case of breakthrough fungal pericarditis due to fluconazole resistant Candida auris in a patient with chronic liver disease. JMM Case Rep 2014; doi:10.1099/jmmcr.0.T00018
26. Kumar D, Banerjee T, Pratap CB et al. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries 2015; 9: 435-7
27. Cornely OA, Bassetti M, Calandra T et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 Suppl 7: 19-37
28. Espinel-IngroffA, Arendrup MC, PfallerMA et al. Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 2013; 57: 5836-42